Posted in | News | Gold | Mining Business

Golden Phoenix Minerals to Earn 80% Interest in Coyote Fault Property

Golden Phoenix Minerals, Inc. (OTC Bulletin Board: GPXM) has announced that Phase-I geologic mapping and sampling of its Coyote Fault Gold and Silver Project is scheduled to begin next week.

Golden Phoenix has retained Silver Spartan LLC to perform a Phase-I geologic mapping and sampling program on the Coyote Fault property. Earlier this month, Silver Spartan completed a similar Phase-I program on the Company's Vanderbilt Silver and Gold Project ("Vanderbilt").  Both properties are adjacent to the Mineral Ridge property, in which the Company maintains a thirty percent (30%) interest via its membership interest in Mineral Ridge Gold, LLC; the joint venture entity that owns and operates the Mineral Ridge property with Scorpio Gold.

"Silver Spartan's field geologists have significant experience in the Mineral Ridge area," stated Tom Klein, CEO of Golden Phoenix. "They expect to have the Phase-I Report completed at or near the end of December."

Golden Phoenix has acquired an option to earn an 80% interest in Coyote Fault from Mhakari Gold (Nevada) ("Mhakari").  Mhakari's initial assessment indicates Coyote Fault may be one of the primary geologic structures associated with known gold mineralization on Mineral Ridge.

Mr. Klein concluded: "The Mineral Ridge area is continuing to demonstrate what we believe is a solid geological foundation. Our development of Coyote Fault and the Vanderbilt, along with Scorpio Gold's development of Mineral Ridge, are providing continuous advancement of the Mineral Ridge district."

Source:

Golden Phoenix Minerals, Inc.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.